4//SEC Filing
Meyenburg Jason Patrick 4
Accession 0001209191-22-001634
CIK 0001816736other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:08 PM ET
Size
9.9 KB
Accession
0001209191-22-001634
Insider Transaction Report
Form 4
Meyenburg Jason Patrick
DirectorPresident & CEO
Transactions
- Award
Restricted Stock Units
2022-01-03+123,600→ 123,600 total→ Common Stock (123,600 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
- [F2]These Restricted Stock Units shall vest in accordance with certain performance based metrics.
Documents
Issuer
Gemini Therapeutics, Inc. /DE
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001709008
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:08 PM ET
- Size
- 9.9 KB